Potential mechanism of the involvement of the transcription factor c-Fos in delaying EGFR-TKI acquired resistance by radiotherapy through regulation of the ERK1/2 pathway
讲者：彭林
单位：华中科技大学同济医学院附属同济医院
非小细胞肺癌2.5D类器官模型的免疫微环境建立
讲者：李慧
单位：吉林省肿瘤医院
一例朗格汉斯细胞组织细胞增生症病历分享及文献回顾
讲者：顾康生
单位：安徽医科大学第一附属医院
A phase 3 study of serplulimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer: ASTRUM-004 Chinese subgroup
讲者：熊安稳
单位：上海市东方医院
A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma
讲者：张欣
单位：重庆大学附属肿瘤医院
Pembrolizumab Plus Gemcitabine and Cisplatin Versus Placebo Plus Gemcitabine and Cisplatin as First-Line Therapy for Advanced Biliary Tract Cancer: Results for the China Subpopulation From the Phase 3 KEYNOTE-966 Study
讲者：秦叔逵
单位：中国药科大学附属南京天印山医院
Limited Efficacy of EGFR-TKIs in NSCLC Patients with EGFR Mutations and High PD-L1 Expression: A Single-Center Retrospective Analysis
讲者：吴鑫宇
单位：中国医学科学院肿瘤医院
IMpower010: Final DFS and second OS interim analysis result from Asian patients after ≥5 years of follow-up of a Phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA
讲者：李玮
局部进展期胃癌新辅助免疫治疗共识与争议
讲者：张小田
单位：北京大学肿瘤医院
肿瘤RNA疫苗的研究进展与前景
讲者：宋尔卫
单位：中山大学孙逸仙纪念医院
